Abbott’s neuromodulation systems can significantly reduce pain-related healthcare visits for people living with chronic pain, according to five-year data.
Abbott Laboratories ( ABT) Q4 2025 Earnings Call January 22, 2026 9:00 AM EST Good morning, and thank you for standing by.
School is back in session for the pupils and teachers of Abbott Elementary after a much-needed winter break. After learning some not-so good news about the state of the school, the Abbott crew is ...
After Abbott Elementary Season 5’s iconic birthday/holiday episode, featuring the return of guest star Taraji P. Henson, the Emmy-winning comedy is a brief hiatus. Season 5, Episode 8, “Birthday,” saw ...
The partnership is similar to one between Dexcom and Oura. The partnership is similar to one between Dexcom and Oura. is a senior reporter and author of the Optimizer newsletter. She has more than 13 ...
In a first, this week the U.S. Food and Drug Administration approved a brain stimulation device designed to treat depression at home. The approval of the first such device for home depression ...
In a major shift for how mental health conditions might be treated, the US Food and Drug Administration (FDA) has approved the first at-home brain-stimulation device to treat moderate to severe major ...
Swedish neurotech startup Flow Neuroscience has secured FDA approval for the first brain stimulation device for home use in treating depression, a regulatory milestone that could reshape a mental ...